AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 86 filers reported holding AVROBIO INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $6,288,000 | -64.0% | 1,633,333 | -47.9% | 0.22% | -59.9% |
| Q3 2021 | $17,484,000 | -37.2% | 3,133,333 | 0.0% | 0.54% | -42.7% |
| Q2 2021 | $27,855,000 | -29.9% | 3,133,333 | 0.0% | 0.94% | -31.2% |
| Q1 2021 | $39,762,000 | -9.0% | 3,133,333 | 0.0% | 1.36% | -11.0% |
| Q4 2020 | $43,679,000 | -6.8% | 3,133,333 | -13.0% | 1.53% | +24.0% |
| Q3 2020 | $46,872,000 | +99.0% | 3,600,000 | +166.7% | 1.24% | -8.3% |
| Q2 2020 | $23,558,000 | +12.1% | 1,350,000 | 0.0% | 1.35% | +7.5% |
| Q1 2020 | $21,006,000 | +73.9% | 1,350,000 | +125.0% | 1.25% | +103.9% |
| Q4 2019 | $12,078,000 | +71.1% | 600,000 | +20.0% | 0.62% | +65.8% |
| Q3 2019 | $7,060,000 | – | 500,000 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,736,027 | $45,555,000 | 28.05% |
| Aisling Capital Management LP | 736,998 | $12,271,000 | 12.93% |
| Cormorant Asset Management, LP | 1,357,784 | $22,607,000 | 1.84% |
| New Leaf Venture Partners, L.L.C. | 215,550 | $3,589,000 | 0.98% |
| Eventide Asset Management | 928,891 | $14,901,000 | 0.66% |
| EMERALD ADVISERS, LLC | 380,636 | $6,338,000 | 0.31% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 372,865 | $6,208,000 | 0.29% |
| Blackstone Inc. | 2,962,325 | $49,323,000 | 0.28% |
| PFM Health Sciences, LP | 241,413 | $4,020,000 | 0.11% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 143,762 | $2,394,000 | 0.10% |